Snore-ceasing implant
A technology of implants and bodies, applied in the field of medical devices, can solve the problems of large individual differences in treatment effects and inability to achieve precise control, and achieve the effects of small surgical effects, small deviations, and increased cross-sectional area
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Such as figure 1 As shown, the anti-snoring implant disclosed in this embodiment includes a body made of degradable material through injection molding process. Degradable materials include polyglycolide, polylactide, polycaprolactone, or polydioxanone, or copolymers or blends of the above materials. A preferred embodiment is: the degradable material adopts poly(glycolide-caprolactone) copolymer and polydioxanone. In this embodiment, the main body is processed by injection molding process using poly(glycolide-caprolactone) copolymer, and the degradation period is 6 months.
[0027] When defining the use of the instrument, the end away from the operator is the distal end, and the end close to the operator is the proximal segment. In this embodiment, from the distal end to the proximal end, the body has the distal anchoring pawl 1 , the distal connecting rod 2 , the middle contraction section 3 , the proximal connecting rod 4 and the proximal anchoring ring 5 .
[0028]...
Embodiment 2
[0032] Such as image 3 As shown, the difference between the anti-snoring implant disclosed in this embodiment and Embodiment 1 is:
[0033] 1) The body is made of poly(glycolide-L-lactide) copolymer through injection molding process, and the degradation cycle is 5 months.
[0034] 2) The middle shrinkage section 3 is a continuous V-shaped structure in which multiple V-shaped ends are connected end to end.
[0035] 3) When the body is in a natural state, the length of the body is 16 mm, and the length of the middle contraction section 3 is 5 mm. The maximum outer diameter of the body is 2.6mm. After loading into the delivery system, the body is stretched to 26 mm with a maximum outer diameter of 2.0 mm.
[0036] Other structures and working principles of this embodiment are the same as those of Embodiment 1.
Embodiment 3
[0038] Such as Figure 4 As shown, the difference between the anti-snoring implant disclosed in this embodiment and Embodiment 1 is:
[0039] 1) The main body is woven from polydioxanone silk, and the degradation cycle is 6 months.
[0040] 2) The middle shrinkage section 3 is a spiral structure.
[0041] 3) When the body is in a natural state, the length of the body is 15 mm, and the length of the middle contraction section 3 is 5.5 mm. The maximum outer diameter of the body is 2.1mm. After loading into the delivery system, the body is stretched to 27mm and has a maximum outer diameter of 1.85mm.
[0042] 4) The anti-snoring implant is implanted into the body by a needle delivery device. Before implantation, the distal end of the implant is secured on a needle and the proximal end is stretched by a thread. When reaching the lesion site, the implant is released in the body, and during the recovery process of the middle contraction section 3, the tissue and the barbs are c...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


